Finance

Lists
Why is 6OP down 15,98%?
Dive Deeper
6OP:FRA
Ose Immunotherapeutics SA
€2,01
-15,98%
(-0,38) 1D
20 Okt., 08:05:55 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6OP...
Open
€2,01
High
€2,01
Low
€2,01
Mkt. cap
46,45 m
Avg. vol.
80,00
Volume
0,00
52-wk high
€6,20
52-wk low
€1,98
EPS
-€1,69
No. of employees
64
Open
€2,01
High
€2,01
Low
€2,01
Mkt. cap
46,45 m
Avg. vol.
80,00
Volume
0,00
52-wk high
€6,20
52-wk low
€1,98
EPS
-€1,69
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 Nov. 2004
Headquarters-
Sector-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2024
Des. 2024
Revenue
431,00 k
431,00 k
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 m
8,28 m
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 m
1,08 m
Operating expense
10,22 m
10,22 m
Total operating expenses
10,22 m
10,22 m
Operating income
-9,79 m
-9,79 m
Other non operating income
-611,00 k
-611,00 k
EBT including unusual items
-10,44 m
-10,44 m
EBT excluding unusual items
-10,53 m
-10,53 m
Income tax expense
-576,50 k
-576,50 k
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 k
41,00 k
Net income
-9,86 m
-9,86 m
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 k
571,00 k
Interest expense
-707,50 k
-707,50 k
Net interest expenses
-136,50 k
-136,50 k
Depreciation and amortization charges
-
-
EBITDA
-9,74 m
-9,74 m
Gain or loss from assets sale
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme